The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

Expert Opinion on Therapeutic Targets

Volumn 6, Issue 5, 2002, Pages 555-561

  Kaidanovich, Oksana ^a   Eldar Finkelman, Hagit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Glycogen synthase kinase 3 (GSK 3); Inhibitors; Insulin resistance; Type 2 diabetes

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; SB 41528; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; REVIEW;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LITHIUM; MICE; MICE, KNOCKOUT; OBESITY; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0036398986     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.6.5.555     Document Type: Review

References (60)

1. WOODGETT JR: Molecular cloning and expression of glycogen synthase kinase-3/ factor A. EMBO J. (1990) 9:2431-2438.
2. FRAME S, COHEN P: GSK-3 takes center stage more than 20 years after its discovery. Biochem. J. (2001) 359:1-16.
3. GRIMES CA, JOPE RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. (2001) 65:391-426.
4. ELDAR-FINKELMAN H: Glycogen synthase kinase-3: an emerging therapeutic target. Trend. Mol. Med. (2002) 8:126-132.
5. CROSS DA, ALESSI DR, VANDENHEEDE JR, MCDOWELL HE, HUNDAL HS COHEN P: The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor-1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem. J (1994) 303:21-26.
6. WELSH GI, PROUD CG: Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J. (1993) 294:625-629.
7. MOULE SK, WELSH GI, EDGELL NJ, FOULSTONE EJ, PROUD CG, DENTON RM: Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonist in rat epididymal fat cells. J. Biol. Chem. (1997) 272:7713-7719.
8. CROSS DA, ALESSI DR, COHEN P, ANDJELKOVICH M, HEMMINGS BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature (1995) 378:785-789.
9. GOODE N, HUGHES K, WOODGETT JR, PARKER PJ: Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol. Chem. (1992) 267:16878-16882.
10. TSUJIO I, TANAKA T, KUDO T et al.: Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett. (2000) 469:111-117.
11. FANG X, YU SX, LU Y, BAST RC JR, WOODGETT JR, MILLS GB: Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. USA (2000) 97:11960-11965.
12. SUTHERLAND C, LEIGHTON IA, COHEN P: Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. (1993) 295:15-19.
13. ELDAR-FINKELMAN H, SEGER R, VANDENHEEDE JR, KREBS EG: Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. (1995) 270:987-990.
14. STAMBOLIC V, WOODGETT JR: Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem. J. (1994) 303:701-704.
15. SIEGFRIED E, CHOU TB, PERRIMON N: Wingless signaling acts through zestewhite 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell (1992) 71:1167-1179.
16. COOK D, FRY M, HUGHES K, SUMATHIPALA R, WOODGETT J, DALE T: Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involved a protein kinase C. EMBO J. (1996) 15:4526-4536.
17. ROBINSON LJ, RAZZACK ZF, LAWRENCE JC, JAMES DE: Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes. J. Biol. Chem. (1993) 268:26422-26427.
18. SHAW M, COHEN P: Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase-3 in Swiss 3T3 cells. FEBS Lett. (1999) 461:120-124.
19. PLYTE SE, HUGHES K, NIKOLAKAKI E, PULVERER BJ, WOODGETT JR: Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta (1992) 1114:147-162.
20. TER HAAR E, COLL JT, AUSTEN DA, HSIAO HM, SWENSON L, JAIN J: Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol (2001) 8:593-596.
21. DAJANI R, FRASER E, ROE SM et al.: Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell (2001) 105:721-732.
22. FRAME S, COHEN P, BIONDI RM: A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell (2001) 7:1321-1327.
23. ELDAR-FINKELMAN H, AGRAST GM, FOORD O, FISCHER EH, KREBS EG: Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity. Proc. Natl. Acad. Sci. USA (1996) 93:10228-10233.
24. WOODGETT JR, COHEN P: Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim. Biophys. Acta (1984) 788:339-347.
25. WANG Y, ROACH PJ: Inactivation of rabbit muscle glycogen synthase by glycogen synthase kinase-3. Dominant role of the phosphorylation of Ser-640 (site-3a). J. Biol. Chem. (1993) 268:23876-23680.
26. SUMMERS S, KAO A, KOHN A et al.: The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J. Biol. Chem. (1999) 274:17934-17940.
27. Dambsbo P, Vaag A, Hothernielsen O, Beck-Nielsen H: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 34:239-245.
28. HENRY RR, CIARALDI TP, ABRAMS-CARTER L, MUDALIAR S, PARK KS, NIKOULINA SE: Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J. Clin. Invest. (1996) 98:1231-1236.
29. THORBURN A, ANDRIKOPOULOS S, PROIETTO J: Defects in liver and muscle glycogen metabolism in neonatal and adult New Zealand obese mice. Metabolism (1995) 44:1298-1302.
30. RODEN M, SHULMAN GI: Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Ann. Rev. Med. (1999) 50:277-290.
31. SHULMAN GI: Cellular mechanisms of insulin resistance in humans. Am. J. Cardiol. (1999) 84:3J-10J.
32. DENT P, LAVOINNE A, NAKIELNY S, CAUDWELL FB, WATT P, COHEN P: The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature (1990) 348:302-308.
33. WHITE MF: The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog. Horm. Res. (1998) 53:119-138.
34. VIRKAMAKI A, UEKI K, KAHN R: Protein-protein 4 interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. (1998) 103(7):931-943.
35. SUN XJ, ROTHENBERG P, KAHN CR et al.: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature (1991) 352:73-77.
36. TANTI JF, GREMEAUX T, VAN OBBERGHEN E, LE MARCHAND-BRUSTEL Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol. Chem. (1994) 269:6051-6057.
37. HOTAMISLIGIL GS, PERALDI P BUDAVARI A, ELLIS R, WHITE MF, SPIEGELMAN BM: IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity induced insulin resistance. Science (1996) 271:665-658.
38. ELDAR-FINKELMAN H, KREBS EG: Phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 impairs insulin action. Proc. Natl. Acad. Sci. (1997) 94:9660-9664.
39. AGUIRRE V, UCHIDA T, YENUSH L, DAVIS R, WHITE M: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. (2000) 275:9047-9054.
40. FEA KD, ROTH R: Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry (1998) 36:12939-12947.
41. PAZ K, LIU YF, SHORER H et al.: Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function J. Biol. Chem. (1999) 274:28816-28822.
42. QIAO LY, ZHANDE R, JETTON TL, ZHOU G, SUN XJ: In vivo phosphorylation of IRS-1 at serine 789 by a novel serine kinase in insulin resistant rodents. J. Biol. Chem. (1999) 277:26530-26539.
43. MORFINI G, SZEBENYI G, ELLURU R, RATNER N, BRADY ST. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. (2002) 21:281-293.
44. EMOTO M, LANGILLE SE, CZECH MP: A role for kinesin in insulin-stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes. J. Biol. Chem. (2001) 276:10677-10682.
45. ELDAR-FINKELMAN H, SCHREYER SA, SHINOHARA MM, LEBOEUF RC, KREBS EG: Increased glycogen synthase kinase-3 activity in diabetes and obesity prone C57BL/6J mice. Diabetes (2001) 48:1662-1666.
46. NIKOULINA SE, CIARALDI TP, MUDAILAR S, MOHIDEEN P, CARTER L, HENRY RR: Potential role of GSK-3 in skeletal muscle insulin resistance Type 2 diabetes. Diabetes (2000) 49:263-271.
47. BERGMAN RN, MITTELMAN SD: Central role of adipocyte in insulin resistance. J. Basic. Clin. Physiol. Pharmacol. (1998) 2-4:205-219.
48. JOHNSON AB, ARGYRAKI M, THOW JC, COOPER BG, FULCHER G, TAYLOR R: Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin. Sci. (1992) 82:219-226.
49. ROSS SE, ERICKSON RL, HEMATI N, MACDOUGALD OA: Glycogen synthase kinase-3 is an insulin-regulated C/EBP alpha kinase. Mol. Cell. Biol. (1999) 19:8433-8441.
50. BRUN RP, SPIEGELMAN BM: PPAR gamma and the molecular control of adipogenesis. J. Endocrin. (1997) 155:217-218.
51. MANJI HM, MOORE GJ, CHEN G: Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol. Psychiatry (1999) 46:929-940.
52. CHENG K, CREACY S, LARNER J: 'Insulin-like' effects of lithium ion on isolated rat adipocytes. I. Stimulation of glycogenesis beyond glucose transport. Mol. Cell. Biochem. (1983) 56:177-182.
53. NYFELER F, WALTER P: Effect of lithium on glycogen synthesis in hepatocytes from rat liver. FEBS Lett. (1979) 108:197-199.
54. KLEIN PS, MELTON DA: A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA (1996) 93:8455-8459.
55. STAMBOLIC V, RUEL L, WOODGETT JR: Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells. Curr. Biol. (1996) 6:1664-1668.
56. COGHLAN MP, CULBERT AA, CROSS DA et al.: Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. (2000) 7:793-803.
57. NIKOULINA SE, CIARALDI TP, MUDALIAR S, CARTER L, JOHNSON K, HENRY RR: Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes (2002) 51:2190-2198.
58. HANSEN L, ARDEN K, RASMUSSEN S et al.: Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM. Diabetologia (1997) 40(8):940-946.
59. HOEFLICH KP, LUO J, RUBIE EA, TSAO MS, JIN O, WOODGETT JR: Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappa B activation. Nature (2000) 406:86-90.
60. PEIFER M, POLAKIS P: Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science (2000) 287:1606-1609.